Literature DB >> 30364834

Validity of electronic hospital discharge prescription records as a source of medication data for pharmacoepidemiological research.

Laura Fanning1, Lilian Vo2, Jenni Ilomäki2, J Simon Bell2, Rohan A Elliott2, Pēteris Dārziņš3.   

Abstract

BACKGROUND: The advent of hospital electronic medical records (EMRs) with electronic prescribing provides considerable opportunity for pharmacoepidemiological research. However, validity of EMR prescribing data for research purposes is not well established. Validity concerns the percentage of cases in which medications and characteristics (name, type, formulation, dose) are true when verified with an independent data source. This study evaluated the validity of EMR discharge prescription data within the Eastern Health hospital network in Melbourne, Australia.
METHODS: A random sample of patients were selected who had a diagnosis of atrial fibrillation (AF) and were prescribed at least five medications. Prescription records from 2012 to 2015 were compared with pharmacy dispensing and hospital medical records (reference standards). Medication name, dose, directions and route of administration were compared. Discrepancies between data sources were categorized as omissions, additions, discrepancies in dose, medication form or route of administration or discrepancies in reordering. Sensitivities and 95% confidence intervals (CIs) for intended medication exposure were estimated for therapeutic classes.
RESULTS: A total of 5724 prescription orders for 479 patients for whom reference standards were available were included. There were 163 discrepancies (2.8%) between prescription records and reference standards. Additions were the most common data discrepancy (n = 65; ~1.1% of total prescriptions evaluated), followed by discrepancies in reordering (n = 34; 0.59%). Sensitivities for intended patient exposure to a medication for each therapeutic class at the first level of the Anatomical Therapeutic Chemical (ATC) classification system were between 97% and 100%. The genitourinary system and sex hormone level of the ATC system demonstrated the lowest sensitivity, (97.3%; 95% CI 92.0%-100%) and the cardiovascular system level demonstrated the highest sensitivity (99.9%; 95% CI 99.7%-100%).
CONCLUSION: EMR discharge prescription records for patients with AF are a valid information source for conducting pharmacoepidemiological research within Eastern Health in Melbourne, Australia. Further studies in different regions, countries and patient cohorts are required to establish validity of hospital EMR prescription records for pharmacoepidemiological research.

Entities:  

Keywords:  electronic medical record; hospital discharge prescription records; pharmacoepidemiology; validation studies

Year:  2018        PMID: 30364834      PMCID: PMC6199684          DOI: 10.1177/2042098618776598

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  30 in total

1.  What are the costs of atrial fibrillation?

Authors:  Carina Blomstrom Lundqvist; Gregory Y H Lip; Paulus Kirchhof
Journal:  Europace       Date:  2011-05       Impact factor: 5.214

2.  Counterpoint: the treatment decision design.

Authors:  M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-10-26       Impact factor: 4.897

3.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

4.  30-Day Potentially Avoidable Readmissions Due to Adverse Drug Events.

Authors:  Olivia Dalleur; Patrick E Beeler; Jeffrey L Schnipper; Jacques Donzé
Journal:  J Patient Saf       Date:  2021-08-01       Impact factor: 2.844

Review 5.  Registry evaluation methods: a review and case study.

Authors:  J Goldberg; H M Gelfand; P S Levy
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

8.  Use of electronic medical records in oncology outcomes research.

Authors:  Gena Kanas; Libby Morimoto; Fionna Mowat; Cynthia O'Malley; Jon Fryzek; Robert Nordyke
Journal:  Clinicoecon Outcomes Res       Date:  2010-02-24

9.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.

Authors:  Xiaoxi Yao; Neena S Abraham; G Caleb Alexander; William Crown; Victor M Montori; Lindsey R Sangaralingham; Bernard J Gersh; Nilay D Shah; Peter A Noseworthy
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

10.  Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.

Authors:  Heidi Taipale; Antti Tanskanen; Marjaana Koponen; Anna-Maija Tolppanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  Clin Epidemiol       Date:  2016-10-11       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.